Search - tctmd.com

Displaying 81 - 100 of 5458

Sort: Relevancy | Date

Presentation TCT 2025

ICE-Guided LAAC Imaging – A Lens Into the Future

Presenter: Shephal K. Doshi

October 28, 2025

Presentation TCT 2025

TCT 734: Three-year clinical outcomes of left atrial appendage occlusion with or without ablation: insight from the RECORD study

Presenter: Chao Gao

October 28, 2025

Presentation TCT 2025

Digital Versus Invasive Assessment of Functional Lesion Significance: Are Clinical Outcomes Studies Needed If the In Vivo Correlations are Great?

Presenter: Bon-Kwon Koo

October 28, 2025

Presentation TCT 2025

Controversial Management of LAAC Complications: Device Related Thrombus and Peri-Device Leaks

Presenter: Devi G. Nair

October 28, 2025

Presentation TCT 2025

TCT 849: Clinical and Economic Consequences of Delayed TAVR among Patients with Clinically Significant Aortic Senosis

Presenter: Curtiss T. Stinis

October 28, 2025

Presentation TCT 2025

How Should Clinicians Interpret Class 2a and 2b Guidelines Recommendations

Presenter: Jacqueline E. Tamis-Holland

October 28, 2025

Presentation TCT 2025

Incidence and Clinical Consequences of Conduction Disturbances After TAVR

Presenter: Amit N. Vora

October 28, 2025

Presentation TCT 2025

Choosing the Optimal LAAC Device Based Upon Anatomical Considerations

Presenter: Jason H. Rogers

October 28, 2025

Presentation TCT 2025

Tips and Tools for Transseptal Access (and Iatrogenic ASD Management) and Vascular Access and Closure

Presenter: Rahul Prakash Sharma

October 28, 2025

Presentation TCT 2025

Should Sham Control vs Open Trial Design Make a Difference for Device Regulators and Guideline Makers?

Presenter: Gregg W. Stone

October 28, 2025

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Todd Neale

October 27, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News TCT 2025

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

Yael L. Maxwell

October 27, 2025

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Caitlin E. Cox

October 27, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

The SmartWave Lithotripsy System for Valvular Heart Disease Treatment: Technology Description and Early Clinical Results

Presenter: Kent Chak-yu So

October 27, 2025

Presentation TCT 2025

Leverage Artificial Intelligence in Clinical Trials: Opportunities and Challenges

Presenter: Alexandra Popma

October 27, 2025

Presentation TCT 2025

TCT 615: Clinical Outcomes of the First 200 Cases of Single-Operator TEE-Guided Left Atrial Appendage Occlusion

Presenter: Hafez Golzarian

October 27, 2025

Presentation TCT 2025

The Challenges of Recurrent Event Models and Multiple Endpoints

Presenter: Daniele Giacoppo

October 27, 2025

Presentation TCT 2025

TCT 770: Clinical Outcomes of Combined RAAS Inhibitor and Statin Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis

Presenter: Amer Hussein Muhyieddeen

October 27, 2025

Advertisement

ICE-Guided LAAC Imaging – A Lens Into the Future

TCT 734: Three-year clinical outcomes of left atrial appendage occlusion with or without ablation: insight from the RECORD study

Digital Versus Invasive Assessment of Functional Lesion Significance: Are Clinical Outcomes Studies Needed If the In Vivo Correlations are Great?

Controversial Management of LAAC Complications: Device Related Thrombus and Peri-Device Leaks

TCT 849: Clinical and Economic Consequences of Delayed TAVR among Patients with Clinically Significant Aortic Senosis

How Should Clinicians Interpret Class 2a and 2b Guidelines Recommendations

Incidence and Clinical Consequences of Conduction Disturbances After TAVR

Choosing the Optimal LAAC Device Based Upon Anatomical Considerations

Tips and Tools for Transseptal Access (and Iatrogenic ASD Management) and Vascular Access and Closure

Should Sham Control vs Open Trial Design Make a Difference for Device Regulators and Guideline Makers?

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

The SmartWave Lithotripsy System for Valvular Heart Disease Treatment: Technology Description and Early Clinical Results

Leverage Artificial Intelligence in Clinical Trials: Opportunities and Challenges

TCT 615: Clinical Outcomes of the First 200 Cases of Single-Operator TEE-Guided Left Atrial Appendage Occlusion

The Challenges of Recurrent Event Models and Multiple Endpoints

TCT 770: Clinical Outcomes of Combined RAAS Inhibitor and Statin Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content